These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

454 related items for PubMed ID: 21549900

  • 21. [Therapy of venous thromboembolism].
    Niederer A, Wuillemin WA.
    Praxis (Bern 1994); 2001 Feb 08; 90(6):213-9. PubMed ID: 11235642
    [Abstract] [Full Text] [Related]

  • 22. Low-molecular-weight heparins in the treatment of cancer-associated thrombosis: a new standard of care?
    Burris HA.
    Semin Oncol; 2006 Apr 08; 33(2 Suppl 4):S3-16; quiz S41-2. PubMed ID: 16638456
    [Abstract] [Full Text] [Related]

  • 23. Prevention of venous thromboembolism in cancer patients.
    Kakkar AK, Williamson RC.
    Semin Thromb Hemost; 1999 Apr 08; 25(2):239-43. PubMed ID: 10357091
    [Abstract] [Full Text] [Related]

  • 24. [Venous thromboembolism and cancer].
    Meyer G.
    Rev Prat; 2015 Feb 08; 65(2):216-9. PubMed ID: 25939227
    [Abstract] [Full Text] [Related]

  • 25. [Venous thromboembolism associated with long-term use of central venous catheters in cancer patients].
    Debourdeau P, Chahmi DK, Zammit C, Farge-Bancel D.
    Pathol Biol (Paris); 2008 Jun 08; 56(4):211-9. PubMed ID: 18395994
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Extended-duration low-molecular-weight heparin prophylaxis following total joint arthroplasty.
    Whang PG, Lieberman JR.
    Am J Orthop (Belle Mead NJ); 2002 Sep 08; 31(9 Suppl):31-6. PubMed ID: 12349893
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Treatment of venous thromboembolism in cancer patients.
    Levine MN, Lee AY.
    Semin Thromb Hemost; 1999 Sep 08; 25(2):245-9. PubMed ID: 10357092
    [Abstract] [Full Text] [Related]

  • 33. Venous thromboembolism (VTE) in patients with cancer: epidemiology and risk factors.
    Wun T, White RH.
    Cancer Invest; 2009 Sep 08; 27 Suppl 1():63-74. PubMed ID: 19291526
    [Abstract] [Full Text] [Related]

  • 34. Heparin and low-molecular-weight heparin therapy for venous thromboembolism. The twilight of anticoagulant monitoring.
    Hull RD, Pineo GF, Stein P.
    Int Angiol; 1998 Dec 08; 17(4):213-24. PubMed ID: 10204652
    [Abstract] [Full Text] [Related]

  • 35. Venous thromboembolism: risk factors for recurrence.
    Zhu T, Martinez I, Emmerich J.
    Arterioscler Thromb Vasc Biol; 2009 Mar 08; 29(3):298-310. PubMed ID: 19228602
    [Abstract] [Full Text] [Related]

  • 36. A review of the practical advantages of low molecular weight heparin in the treatment of cancer-related venous thromboembolism.
    Rhodes S, Bond S.
    Eur J Oncol Nurs; 2008 Dec 08; 12(5):425-9. PubMed ID: 18842458
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Prevention of deep vein thrombosis in cancer patients.
    Lee AY.
    Semin Thromb Hemost; 2007 Oct 08; 33(7):699-706. PubMed ID: 18000798
    [Abstract] [Full Text] [Related]

  • 39. Role of anticoagulation in the management of pancreatic cancer.
    Sohail MA, Saif MW.
    JOP; 2009 Mar 09; 10(2):82-7. PubMed ID: 19287098
    [Abstract] [Full Text] [Related]

  • 40. The treatment of venous thromboembolism in patients with cancer.
    Prandoni P.
    Intern Emerg Med; 2010 Oct 09; 5 Suppl 1():S27-30. PubMed ID: 20865471
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.